These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 15782399)

  • 1. Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 gene might be a risk factor for diabetic retinopathy in Slovene population (Caucasians) with type 2 diabetes and the Pro12Ala polymorphism of the PPARgamma gene is not.
    Petrovic MG; Kunej T; Peterlin B; Dovc P; Petrovic D
    Diabetes Metab Res Rev; 2005; 21(5):470-4. PubMed ID: 15782399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Gly482Ser polymorphism of the peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) gene is associated with type 2 diabetes in Caucasians.
    Kunej T; Globocnik Petrovic M; Dovc P; Peterlin B; Petrovic D
    Folia Biol (Praha); 2004; 50(5):157-8. PubMed ID: 15581067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common polymorphisms of the peroxisome proliferator-activated receptor-gamma (Pro12Ala) and peroxisome proliferator-activated receptor-gamma coactivator-1 (Gly482Ser) and the response to pioglitazone in Chinese patients with type 2 diabetes mellitus.
    Hsieh MC; Lin KD; Tien KJ; Tu ST; Hsiao JY; Chang SJ; Lin SR; Shing SJ; Chen HC
    Metabolism; 2010 Aug; 59(8):1139-44. PubMed ID: 20045142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
    Zhou TB; Guo XF; Yin SS
    J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and Asians.
    Ma J; Li Y; Zhou F; Xu X; Guo G; Qu Y
    Mol Vis; 2012; 18():2352-60. PubMed ID: 22993484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma/Pro12Ala polymorphism and peroxisome proliferator-activated receptor gamma coactivator-1 alpha/Gly482Ser polymorphism in patients with sarcoidosis.
    Maver A; Medica I; Salobir B; Tercelj-Zorman M; Sabovic M; Petrovic D; Peterlin B
    Sarcoidosis Vasc Diffuse Lung Dis; 2008 Sep; 25(1):29-35. PubMed ID: 19070258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of polymorphism pro12Ala of PPARgamma gene on endothelium destruction in patients with diabetes mellitus t. 2].
    Gacka M; Dobosz T; Szymaniec S; Bednarska-Chabowska D; Adamiec R
    Pol Arch Med Wewn; 2005 Nov; 114(5):1055-65. PubMed ID: 16789503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to Type II diabetes mellitus.
    Ek J; Andersen G; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Diabetologia; 2001 Dec; 44(12):2220-6. PubMed ID: 11793024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association analysis of PPARγ (p.Pro12Ala) polymorphism with type 2 diabetic retinopathy in patients from north India.
    Kaur N; Vanita V
    Ophthalmic Genet; 2017; 38(3):217-221. PubMed ID: 27427939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alanine variant of the Pro12Ala polymorphism of the PPARgamma gene might be associated with decreased risk of diabetic retinopathy in type 2 diabetes.
    Malecki MT; Cyganek K; Mirkiewicz-Sieradzka B; Wolkow PP; Wanic K; Skupien J; Solnica B; Sieradzki J
    Diabetes Res Clin Pract; 2008 Apr; 80(1):139-45. PubMed ID: 18077048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A possible association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma2 gene with obesity in native Javanese in Indonesia.
    Danawati CW; Nagata M; Moriyama H; Hara K; Yasuda H; Nakayama M; Kotani R; Yamada K; Sakata M; Kurohara M; Wiyono P; Asdie H; Sakaue M; Taniguchi H; Yokono K
    Diabetes Metab Res Rev; 2005; 21(5):465-9. PubMed ID: 15739197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Gly482Ser variant of the PPARGC1 gene is associated with Type 2 diabetes mellitus in northern Chinese, especially men.
    Sun L; Yang Z; Jin F; Zhu XQ; Qu YC; Shi XH; Wang L
    Diabet Med; 2006 Oct; 23(10):1085-92. PubMed ID: 16978372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Gly482Ser missense mutation of the peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects.
    Fanelli M; Filippi E; Sentinelli F; Romeo S; Fallarino M; Buzzetti R; Leonetti F; Baroni MG
    Dis Markers; 2005; 21(4):175-80. PubMed ID: 16403952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance].
    Gacka M; Bednarska-Chabowska D; Dobosz T; Szymaniec S; Jakobsche U; Lebioda A; Adamiec R
    Przegl Lek; 2007; 64(6):393-7. PubMed ID: 18159845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study.
    Herrmann SM; Ringel J; Wang JG; Staessen JA; Brand E;
    Diabetes; 2002 Aug; 51(8):2653-7. PubMed ID: 12145184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of genetic polymorphism peroxisome proliferator-activated receptor-gamma2 Pro12Ala on ethnic susceptibility to diabetes in South-Asian and Caucasian subjects: Evidence for heterogeneity.
    Radha V; Vimaleswaran KS; Babu HN; Abate N; Chandalia M; Satija P; Grundy SM; Ghosh S; Majumder PP; Deepa R; Rao SM; Mohan V
    Diabetes Care; 2006 May; 29(5):1046-51. PubMed ID: 16644635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.